首页> 外文期刊>Indian Journal of Chemical Technology >Simultaneous spectrophotometric estimation and validation of three component tablet formulation containing paracetamol, nimesulide and tizanidine
【24h】

Simultaneous spectrophotometric estimation and validation of three component tablet formulation containing paracetamol, nimesulide and tizanidine

机译:同时测定对乙酰氨基酚,尼美舒利和替扎尼定的三组分片剂的分光光度估计和验证

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, two spectrophotometric methods that do not require prior separation for simultaneous estimation of three drugs: paracetamol, nimesulide, and tizanidine in tablet formulation have been reported. Shimadzu UV-1700, capable of multi-component analysis was used for quantitation. Method I was based on derivative spectrophotometry and the absorbances were measured at 229.5, 271, and 323.0 nm, being the zero crossing points for paracetamol, nimesulide and tizanidine, respectively. Method II is based on multi-wavelength spectroscopic method, absorbances of standard solutions were measured at 229.0 nm, 272.0 nm, 262.0 nm and 323.0 nm based on statistical calculations and results of the sample solutions. All the three drugs obey Beer's law in the concentration range employed for the methods. The results of the analysis for both methods were tested and validated for various parameters according to International Conference on Harmonization Q 2B guidelines. The utility of the developed methods has been demonstrated by analysis of commercially available tablet dosage form.
机译:在本研究中,已有两种分光光度法不需要先分离即可同时估算片剂中的三种药物:扑热息痛,尼美舒利和替扎尼定。使用能够进行多组分分析的Shimadzu UV-1700进行定量。方法I基于导数分光光度法,在229.5、271和323.0 nm处测量吸光度,分别是对乙酰氨基酚,尼美舒利和替扎尼定的零交叉点。方法II是基于多波长光谱法的,基于统计计算和样品溶液的结果,测量了标准溶液的吸光度,分别为229.0 nm,272.0 nm,262.0 nm和323.0 nm。这三种药物在该方法使用的浓度范围内均符合比尔定律。根据国际协调会议Q 2B指南,测试和验证了这两种方法的分析结果的各种参数。通过对市售片剂剂型的分析证明了所开发方法的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号